Prevention of abnormal scarring in woundhealing
S100 proteins (i.e. Psoriasin, Koebnerisin) for the prevention
of abnormal scarring by reduction of excessive collagen and extracellular matrix production early after wounding.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Finding the ship that sent out a warning to The Titanic
New powerful technology reveals lost seabed structures. The ship which sent an iceberg warning to the RMS Titanic, before the ocean-liner sank, has been identified lying in the Irish Sea….
Quantum technology reaches unprecedented control over captured light
Researchers in quantum technology at Chalmers University of Technology have succeeded in developing a technique to control quantum states of light in a three-dimensional cavity. In addition to creating previously…
A master regulator controlling fungal infection of wheat
The fungus Zymoseptoria tritici causes Septoria tritici blotch, the most destructive fungal disease of wheat grown in temperate climates worldwide. This disease reduces wheat yields by 5-10% per year, causing…
